| NCT ID | NCT04049591 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Population Health Research Institute |
| Condition | Cardiovascular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 16,000 participants |
| Start Date | 2022-03-02 |
| Primary Completion | 2024-10-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 16,000 participants in total. It began in 2022-03-02 with a primary completion date of 2024-10-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).
Eligibility Criteria
Inclusion Criteria: \- Patients undergoing elective PCI Exclusion Criteria: * Age \<18 years * Planned chronic total occlusion PCI * Non-resident precluding follow up through local registries Hospital (Cluster) Eligibility Criteria Hospitals will be eligible to participate if they meet the following criteria: * Submit PCI procedure data to a compatible registry that is able to provide data for the trial * Site agrees to manage patients as per the higher or lower dose heparin policy in place during the given crossover period
Contact & Investigator
Sanjit Jolly, MD
PRINCIPAL INVESTIGATOR
Population Health Research Institute
Frequently Asked Questions
Who can join the NCT04049591 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04049591 currently recruiting?
Yes, NCT04049591 is actively recruiting participants. Contact the research team at HD-PCI@phri.ca for enrollment information.
Where is the NCT04049591 trial being conducted?
This trial is being conducted at Hamilton, Canada.
Who is sponsoring the NCT04049591 clinical trial?
NCT04049591 is sponsored by Population Health Research Institute. The principal investigator is Sanjit Jolly, MD at Population Health Research Institute. The trial plans to enroll 16,000 participants.